Clinical Trials Directory

Trials / Completed

CompletedNCT02005926

The Accuracy of Sentinel Node Biopsy of Breast Cancer With Sonographic Abnormal Axillary Lymph Nodes

Phase II Trail of Removing Sonographic Abnormal Lymph Node in Sentinel Lymph Node Biopsy of Breast Cancer Patient

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Tao OUYANG · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

* This is a phase II, prospective, single-center, non-randomized, non-controlled study. * Sentinel lymph node biopsy (SNB) is a standard staging procedure in early breast cancer. The potentially increasing false negative rate of SNB was concerned if the sonographic abnormal node was not excised. The aim of this study was to evaluate the accuracy of SNB in breast cancer with sonographic abnormal axillary lymph nodes.

Conditions

Interventions

TypeNameDescription
PROCEDUREWire-localized abnormal nodeBefore the sentinel lymph node biopsy (SLNB) operation, a hookwire was placed at the suspicious axillary lymph node by ultrasound guidance to localize the abnormal node. In the SLNB operation, radioactive nodes and wire-localized nodes were removed and labeled separately for pathological examination.

Timeline

Start date
2010-05-01
Primary completion
2014-05-01
Completion
2014-06-01
First posted
2013-12-09
Last updated
2014-06-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02005926. Inclusion in this directory is not an endorsement.

The Accuracy of Sentinel Node Biopsy of Breast Cancer With Sonographic Abnormal Axillary Lymph Nodes (NCT02005926) · Clinical Trials Directory